Conference Series extends its welcome to the Global Virtual Summit on Oncology and Radiology during May 11-12, 2023, as a webinar with a theme “Innovatie approaches for treatment of cancer”. RADIOCANCER 2023 Conference will focus on educational research directed toward its impact on clinical outcomes, through oral and poster presentations, educational workshop sessions, and influential plenary presentations. RADIOCANCER 2023 is a perfect platform to find out how cancer and Oncology research innovations helpful to the Medical, Health and human society. Conference will mainly focus on the trending topics during   presentations of the two-day event, which reflect current education, research, developments and innovations internationally in the field of cancer, oncology and medical sectors.

Whatsapp number  +44 1303 610264

Antineoplastic drugs

Most antineoplastic agents are categorized according to their structure or cell cycle activity - either cell cycle phase specific or cell cycle phase non-specific.

Cell cycle phase specific agents act on the cells in a particular phase. They are most active against tumours that have a huge proportion of cells vigorously moving through the cell cycle and cycling at a fast rate. Fast cycling ensures that the cell passes through the phase in which it is susceptible to the drugs' effects.

Cell cycle phase non-specific agents are not dependant on the cell being in a particular phase of the cell cycle for them to work - they disturb cells in all stages of the cell cycle. Resting cells (phase G0) are as vulnerable as dividing cells to the cytotoxic effects of these agents. As a result, phase non-specific agents have been found to be some of the most effective drugs against slow-growing tumours.

Generally, they are categorized as

(1)alkylating agents,

 (2) antimetabolites,

(3) natural products,

 (4) hormones and antagonists,

 (5) miscellaneous